<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC9194644</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC9194644.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">9194644</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">9194644</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">35696810</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1016/j.nicl.2022.103077</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pii">S2213-1582(22)00142-5</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">103077</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Participants baseline characteristics. Mean (SD) and Count (%) for continuous and categorical variables, respectively.</table-caption><table-wrap-foot>The final samples shown in the table are the total samples utilized. Abbreviations: APOE e4: Apolipoprotein E epsilon 4; BMI: body mass index; HDL: high density lipoprotein; LDL: low density lipoprotein; SBP: systolic blood pressure; DBP: diastolic blood pressure; HbA1c: glycated hemoglobin.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="t0005" orientation="portrait"><label>Table 1</label><caption><p>Participants baseline characteristics. Mean (SD) and Count (%) for continuous and categorical variables, respectively.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1">30–49,<break/>n = 59</th><th colspan="1" rowspan="1">50–59, n = 262</th><th colspan="1" rowspan="1">60–69, n = 540</th><th colspan="1" rowspan="1">70–79, n = 407</th><th colspan="1" rowspan="1">80–89, n = 296</th><th colspan="1" rowspan="1"><inline-formula><mml:math id="M7" altimg="si1.svg"><mml:mrow><mml:mi>P</mml:mi></mml:mrow></mml:math></inline-formula> value</th></tr></thead><tbody><tr><td colspan="7" rowspan="1">Demographics &amp; APOE</td></tr><tr><td colspan="1" rowspan="1">Age</td><td colspan="1" rowspan="1">40.02(5.24)</td><td colspan="1" rowspan="1">54.64(2.46)</td><td colspan="1" rowspan="1">64.59(2.84)</td><td colspan="1" rowspan="1">74.51(2.91)</td><td colspan="1" rowspan="1">83.52(2.94)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Male</td><td colspan="1" rowspan="1">32(54%)</td><td colspan="1" rowspan="1">133(51%)</td><td colspan="1" rowspan="1">272(50%)</td><td colspan="1" rowspan="1">212(52%)</td><td colspan="1" rowspan="1">171(58%)</td><td align="char" colspan="1" rowspan="1">0.32</td></tr><tr><td colspan="1" rowspan="1">APOE e4</td><td colspan="1" rowspan="1">14(24%)</td><td colspan="1" rowspan="1">79(30%)</td><td colspan="1" rowspan="1">154(29%)</td><td colspan="1" rowspan="1">124(30%)</td><td colspan="1" rowspan="1">78(26%)</td><td align="char" colspan="1" rowspan="1">0.661</td></tr><tr><td colspan="1" rowspan="1">BMI</td><td colspan="1" rowspan="1">28.31(5.87)</td><td colspan="1" rowspan="1">29.21(5.4)</td><td colspan="1" rowspan="1">29.49(5.43)</td><td colspan="1" rowspan="1">28.21(4.47)</td><td colspan="1" rowspan="1">26.98(4.2)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="7" rowspan="1">Laboratory results</td></tr><tr><td colspan="1" rowspan="1">LDL</td><td colspan="1" rowspan="1">102.42(31.32)</td><td colspan="1" rowspan="1">109.13(30.92)</td><td colspan="1" rowspan="1">103.76(29.77)</td><td colspan="1" rowspan="1">97.3(29.03)</td><td colspan="1" rowspan="1">90.89(27.32)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">HDL</td><td colspan="1" rowspan="1">55.08(18.03)</td><td colspan="1" rowspan="1">55.64(17.85)</td><td colspan="1" rowspan="1">55.49(17.05)</td><td colspan="1" rowspan="1">55.76(17.36)</td><td colspan="1" rowspan="1">55.09(16.51)</td><td align="char" colspan="1" rowspan="1">0.991</td></tr><tr><td colspan="1" rowspan="1">Triglycerides</td><td colspan="1" rowspan="1">119.56(70.17)</td><td colspan="1" rowspan="1">128.87(65.16)</td><td colspan="1" rowspan="1">130.76(62.01)</td><td colspan="1" rowspan="1">125.95(59.16)</td><td colspan="1" rowspan="1">123.17(53.95)</td><td align="char" colspan="1" rowspan="1">0.425</td></tr><tr><td colspan="1" rowspan="1">Total cholesterol</td><td colspan="1" rowspan="1">181.42(40.46)</td><td colspan="1" rowspan="1">190.57(33.87)</td><td colspan="1" rowspan="1">185.42(35.61)</td><td colspan="1" rowspan="1">178.26(36.32)</td><td colspan="1" rowspan="1">170.6(33.89)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">HbA1c</td><td colspan="1" rowspan="1">5.87(1.32)</td><td colspan="1" rowspan="1">6.04(1.12)</td><td colspan="1" rowspan="1">5.93(1)</td><td colspan="1" rowspan="1">5.95(0.79)</td><td colspan="1" rowspan="1">5.97(0.76)</td><td align="char" colspan="1" rowspan="1">0.912</td></tr><tr><td colspan="1" rowspan="1">SBP</td><td colspan="1" rowspan="1">126.19(15.02)</td><td colspan="1" rowspan="1">131.48(16)</td><td colspan="1" rowspan="1">139.13(18.45)</td><td colspan="1" rowspan="1">141.15(18.5)</td><td colspan="1" rowspan="1">142.49(20.13)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">DBP</td><td colspan="1" rowspan="1">78.42(10.96)</td><td colspan="1" rowspan="1">79.16(9.34)</td><td colspan="1" rowspan="1">78.2(9.98)</td><td colspan="1" rowspan="1">74.14(10.05)</td><td colspan="1" rowspan="1">71.12(10.86)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="7" rowspan="1">Current Clinical Diagnosis</td></tr><tr><td colspan="1" rowspan="1">Cognitively Impaired</td><td colspan="1" rowspan="1">2(3%)</td><td colspan="1" rowspan="1">7(3%)</td><td colspan="1" rowspan="1">29(5%)</td><td colspan="1" rowspan="1">62(15%)</td><td colspan="1" rowspan="1">68(23%)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Diabetes</td><td colspan="1" rowspan="1">3(5%)</td><td colspan="1" rowspan="1">31(12%)</td><td colspan="1" rowspan="1">73(14%)</td><td colspan="1" rowspan="1">74(18%)</td><td colspan="1" rowspan="1">56(19%)</td><td align="char" colspan="1" rowspan="1">0.007</td></tr><tr><td colspan="1" rowspan="1">Hypertension</td><td colspan="1" rowspan="1">6(10%)</td><td colspan="1" rowspan="1">82(31%)</td><td colspan="1" rowspan="1">285(53%)</td><td colspan="1" rowspan="1">273(67%)</td><td colspan="1" rowspan="1">244(82%)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Dyslipidemia</td><td colspan="1" rowspan="1">20(34%)</td><td colspan="1" rowspan="1">169(65%)</td><td colspan="1" rowspan="1">424(79%)</td><td colspan="1" rowspan="1">332(82%)</td><td colspan="1" rowspan="1">254(86%)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="7" rowspan="1">Midlife risk factors</td></tr><tr><td colspan="1" rowspan="1">Midlife physical activity</td><td colspan="1" rowspan="1">8.27(3.55)</td><td colspan="1" rowspan="1">7.39(3.66)</td><td colspan="1" rowspan="1">9.1(4.43)</td><td colspan="1" rowspan="1">9.11(4.27)</td><td colspan="1" rowspan="1">9.15(4.66)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Midlife cognitive activity</td><td colspan="1" rowspan="1">17.07(6.59)</td><td colspan="1" rowspan="1">20.29(8.27)</td><td colspan="1" rowspan="1">18.62(9.22)</td><td colspan="1" rowspan="1">20.94(8.61)</td><td colspan="1" rowspan="1">20.87(9.49)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Smoking status</td><td colspan="1" rowspan="1">21(36%)</td><td colspan="1" rowspan="1">92(35%)</td><td colspan="1" rowspan="1">246(46%)</td><td colspan="1" rowspan="1">205(50%)</td><td colspan="1" rowspan="1">119(40%)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="7" rowspan="1">MRI &amp; DTI</td></tr><tr><td colspan="1" rowspan="1">Abnormal WMH</td><td colspan="1" rowspan="1">0(0%)</td><td colspan="1" rowspan="1">0(0%)</td><td colspan="1" rowspan="1">24(4%)</td><td colspan="1" rowspan="1">65(16%)</td><td colspan="1" rowspan="1">110(37%)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Baseline WMH</td><td colspan="1" rowspan="1">0.18(0.09)</td><td colspan="1" rowspan="1">0.31(0.22)</td><td colspan="1" rowspan="1">0.56(0.61)</td><td colspan="1" rowspan="1">1.02(0.79)</td><td colspan="1" rowspan="1">1.74(1.35)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Genu of the corpus callosum FA</td><td colspan="1" rowspan="1">0.64(0.04)</td><td colspan="1" rowspan="1">0.63(0.04)</td><td colspan="1" rowspan="1">0.61(0.04)</td><td colspan="1" rowspan="1">0.59(0.05)</td><td colspan="1" rowspan="1">0.56(0.05)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Splenium of the corpus callosum FA</td><td colspan="1" rowspan="1">0.69(0.03)</td><td colspan="1" rowspan="1">0.69(0.03)</td><td colspan="1" rowspan="1">0.69(0.04)</td><td colspan="1" rowspan="1">0.68(0.04)</td><td colspan="1" rowspan="1">0.66(0.05)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Body of corpus callosum FA</td><td colspan="1" rowspan="1">0.62(0.03)</td><td colspan="1" rowspan="1">0.61(0.04)</td><td colspan="1" rowspan="1">0.6(0.04)</td><td colspan="1" rowspan="1">0.59(0.04)</td><td colspan="1" rowspan="1">0.56(0.05)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Anterior limb of the internal capsule FA</td><td colspan="1" rowspan="1">0.59(0.03)</td><td colspan="1" rowspan="1">0.59(0.03)</td><td colspan="1" rowspan="1">0.59(0.03)</td><td colspan="1" rowspan="1">0.57(0.04)</td><td colspan="1" rowspan="1">0.56(0.04)</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="7" rowspan="1">Scan statistics</td></tr><tr><td colspan="1" rowspan="1">Scan Interval, years</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">1.25(0.44)</td><td colspan="1" rowspan="1">1.31(0.45)</td><td colspan="1" rowspan="1">1.73(0.77)</td><td colspan="1" rowspan="1">1.78(0.87)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Participants with 2 Scans</td><td colspan="1" rowspan="1">0(0%)</td><td colspan="1" rowspan="1">70(27%)</td><td colspan="1" rowspan="1">200(37%)</td><td colspan="1" rowspan="1">129(32%)</td><td colspan="1" rowspan="1">80(27%)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Participants with 3 Scans</td><td colspan="1" rowspan="1">0(0%)</td><td colspan="1" rowspan="1">11(4%)</td><td colspan="1" rowspan="1">43(8%)</td><td colspan="1" rowspan="1">62(15%)</td><td colspan="1" rowspan="1">36(12%)</td><td colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>The final samples shown in the table are the total samples utilized. Abbreviations: APOE e4: Apolipoprotein E epsilon 4; BMI: body mass index; HDL: high density lipoprotein; LDL: low density lipoprotein; SBP: systolic blood pressure; DBP: diastolic blood pressure; HbA1c: glycated hemoglobin.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Participants baseline characteristics. Mean (SD) and Count (%) for continuous and categorical variables, respectively.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>30–49,n = 59</th><th>50–59, n = 262</th><th>60–69, n = 540</th><th>70–79, n = 407</th><th>80–89, n = 296</th><th><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7" altimg="si1.svg"><mml:mrow><mml:mi>P</mml:mi></mml:mrow></mml:math> value</th></tr></thead><tbody><tr><td colspan="7">Demographics &amp; APOE</td></tr><tr><td>Age</td><td>40.02(5.24)</td><td>54.64(2.46)</td><td>64.59(2.84)</td><td>74.51(2.91)</td><td>83.52(2.94)</td><td/></tr><tr><td>Male</td><td>32(54%)</td><td>133(51%)</td><td>272(50%)</td><td>212(52%)</td><td>171(58%)</td><td align="char">0.32</td></tr><tr><td>APOE e4</td><td>14(24%)</td><td>79(30%)</td><td>154(29%)</td><td>124(30%)</td><td>78(26%)</td><td align="char">0.661</td></tr><tr><td>BMI</td><td>28.31(5.87)</td><td>29.21(5.4)</td><td>29.49(5.43)</td><td>28.21(4.47)</td><td>26.98(4.2)</td><td align="char">&lt;0.001</td></tr><tr><td colspan="7">Laboratory results</td></tr><tr><td>LDL</td><td>102.42(31.32)</td><td>109.13(30.92)</td><td>103.76(29.77)</td><td>97.3(29.03)</td><td>90.89(27.32)</td><td align="char">&lt;0.001</td></tr><tr><td>HDL</td><td>55.08(18.03)</td><td>55.64(17.85)</td><td>55.49(17.05)</td><td>55.76(17.36)</td><td>55.09(16.51)</td><td align="char">0.991</td></tr><tr><td>Triglycerides</td><td>119.56(70.17)</td><td>128.87(65.16)</td><td>130.76(62.01)</td><td>125.95(59.16)</td><td>123.17(53.95)</td><td align="char">0.425</td></tr><tr><td>Total cholesterol</td><td>181.42(40.46)</td><td>190.57(33.87)</td><td>185.42(35.61)</td><td>178.26(36.32)</td><td>170.6(33.89)</td><td align="char">&lt;0.001</td></tr><tr><td>HbA1c</td><td>5.87(1.32)</td><td>6.04(1.12)</td><td>5.93(1)</td><td>5.95(0.79)</td><td>5.97(0.76)</td><td align="char">0.912</td></tr><tr><td>SBP</td><td>126.19(15.02)</td><td>131.48(16)</td><td>139.13(18.45)</td><td>141.15(18.5)</td><td>142.49(20.13)</td><td align="char">&lt;0.001</td></tr><tr><td>DBP</td><td>78.42(10.96)</td><td>79.16(9.34)</td><td>78.2(9.98)</td><td>74.14(10.05)</td><td>71.12(10.86)</td><td align="char">&lt;0.001</td></tr><tr><td colspan="7">Current Clinical Diagnosis</td></tr><tr><td>Cognitively Impaired</td><td>2(3%)</td><td>7(3%)</td><td>29(5%)</td><td>62(15%)</td><td>68(23%)</td><td align="char">&lt;0.001</td></tr><tr><td>Diabetes</td><td>3(5%)</td><td>31(12%)</td><td>73(14%)</td><td>74(18%)</td><td>56(19%)</td><td align="char">0.007</td></tr><tr><td>Hypertension</td><td>6(10%)</td><td>82(31%)</td><td>285(53%)</td><td>273(67%)</td><td>244(82%)</td><td align="char">&lt;0.001</td></tr><tr><td>Dyslipidemia</td><td>20(34%)</td><td>169(65%)</td><td>424(79%)</td><td>332(82%)</td><td>254(86%)</td><td align="char">&lt;0.001</td></tr><tr><td colspan="7">Midlife risk factors</td></tr><tr><td>Midlife physical activity</td><td>8.27(3.55)</td><td>7.39(3.66)</td><td>9.1(4.43)</td><td>9.11(4.27)</td><td>9.15(4.66)</td><td align="char">&lt;0.001</td></tr><tr><td>Midlife cognitive activity</td><td>17.07(6.59)</td><td>20.29(8.27)</td><td>18.62(9.22)</td><td>20.94(8.61)</td><td>20.87(9.49)</td><td align="char">&lt;0.001</td></tr><tr><td>Smoking status</td><td>21(36%)</td><td>92(35%)</td><td>246(46%)</td><td>205(50%)</td><td>119(40%)</td><td align="char">&lt;0.001</td></tr><tr><td colspan="7">MRI &amp; DTI</td></tr><tr><td>Abnormal WMH</td><td>0(0%)</td><td>0(0%)</td><td>24(4%)</td><td>65(16%)</td><td>110(37%)</td><td align="char">&lt;0.001</td></tr><tr><td>Baseline WMH</td><td>0.18(0.09)</td><td>0.31(0.22)</td><td>0.56(0.61)</td><td>1.02(0.79)</td><td>1.74(1.35)</td><td align="char">&lt;0.001</td></tr><tr><td>Genu of the corpus callosum FA</td><td>0.64(0.04)</td><td>0.63(0.04)</td><td>0.61(0.04)</td><td>0.59(0.05)</td><td>0.56(0.05)</td><td align="char">&lt;0.001</td></tr><tr><td>Splenium of the corpus callosum FA</td><td>0.69(0.03)</td><td>0.69(0.03)</td><td>0.69(0.04)</td><td>0.68(0.04)</td><td>0.66(0.05)</td><td align="char">&lt;0.001</td></tr><tr><td>Body of corpus callosum FA</td><td>0.62(0.03)</td><td>0.61(0.04)</td><td>0.6(0.04)</td><td>0.59(0.04)</td><td>0.56(0.05)</td><td align="char">&lt;0.001</td></tr><tr><td>Anterior limb of the internal capsule FA</td><td>0.59(0.03)</td><td>0.59(0.03)</td><td>0.59(0.03)</td><td>0.57(0.04)</td><td>0.56(0.04)</td><td align="char">&lt;0.001</td></tr><tr><td colspan="7">Scan statistics</td></tr><tr><td>Scan Interval, years</td><td/><td>1.25(0.44)</td><td>1.31(0.45)</td><td>1.73(0.77)</td><td>1.78(0.87)</td><td/></tr><tr><td>Participants with 2 Scans</td><td>0(0%)</td><td>70(27%)</td><td>200(37%)</td><td>129(32%)</td><td>80(27%)</td><td/></tr><tr><td>Participants with 3 Scans</td><td>0(0%)</td><td>11(4%)</td><td>43(8%)</td><td>62(15%)</td><td>36(12%)</td><td/></tr></tbody></table></div>The final samples shown in the table are the total samples utilized. Abbreviations: APOE e4: Apolipoprotein E epsilon 4; BMI: body mass index; HDL: high density lipoprotein; LDL: low density lipoprotein; SBP: systolic blood pressure; DBP: diastolic blood pressure; HbA1c: glycated hemoglobin.</transformed-table></extracted-table><extracted-table><table-id>t0010</table-id><table-label>Table 2</table-label><table-caption>Results from two regression (baseline) and two mixed models (progression) on WMH and WM health, Genu-FA.</table-caption><table-wrap-foot>WMH measurements are log-transformed. Higher WMH and lower Genu-FA represent poor brain health. HTN: Hypertension. Other potential variables were dropped out from the stepwise regression. 1564 participants are included in baseline analysis where 1396 are cognitively normal; 740 participants are included in the progression analysis, where 632 are cognitively normal.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="t0010" orientation="portrait"><label>Table 2</label><caption><p>Results from two regression (baseline) and two mixed models (progression) on WMH and WM health, Genu-FA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Model #</th><th colspan="1" rowspan="1">Outcome</th><th colspan="1" rowspan="1">Predictors</th><th colspan="1" rowspan="1">Estimated effect size</th><th colspan="1" rowspan="1">SE</th><th colspan="1" rowspan="1"><inline-formula><mml:math id="M11" altimg="si1.svg"><mml:mrow><mml:mi>P</mml:mi></mml:mrow></mml:math></inline-formula> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"># 1</td><td colspan="1" rowspan="1">Baseline WMH</td><td colspan="1" rowspan="1">Age</td><td align="char" colspan="1" rowspan="1">0.053</td><td align="char" colspan="1" rowspan="1">0.002</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Male</td><td align="char" colspan="1" rowspan="1">−0.183</td><td align="char" colspan="1" rowspan="1">0.033</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">HTN</td><td align="char" colspan="1" rowspan="1">0.172</td><td align="char" colspan="1" rowspan="1">0.037</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1"># 2</td><td colspan="1" rowspan="1">WMH progression</td><td colspan="1" rowspan="1">Age</td><td align="char" colspan="1" rowspan="1">0.060</td><td align="char" colspan="1" rowspan="1">0.003</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Male</td><td align="char" colspan="1" rowspan="1">−0.207</td><td align="char" colspan="1" rowspan="1">0.049</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">HTN</td><td align="char" colspan="1" rowspan="1">0.194</td><td align="char" colspan="1" rowspan="1">0.053</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1"># 3</td><td colspan="1" rowspan="1">Baseline Genu-FA</td><td colspan="1" rowspan="1">Age</td><td align="char" colspan="1" rowspan="1">−0.002</td><td align="char" colspan="1" rowspan="1">0.0001</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Male</td><td align="char" colspan="1" rowspan="1">0.012</td><td align="char" colspan="1" rowspan="1">0.0022</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">HTN</td><td align="char" colspan="1" rowspan="1">−0.010</td><td align="char" colspan="1" rowspan="1">0.0024</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1"># 4</td><td colspan="1" rowspan="1">Genu-FA progression</td><td colspan="1" rowspan="1">Age</td><td align="char" colspan="1" rowspan="1">−0.002</td><td align="char" colspan="1" rowspan="1">0.0002</td><td align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Male</td><td align="char" colspan="1" rowspan="1">0.013</td><td align="char" colspan="1" rowspan="1">0.0034</td><td align="char" colspan="1" rowspan="1">0.001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">HTN</td><td align="char" colspan="1" rowspan="1">−0.011</td><td align="char" colspan="1" rowspan="1">0.0036</td><td align="char" colspan="1" rowspan="1">0.003</td></tr></tbody></table><table-wrap-foot><fn><p>WMH measurements are log-transformed. Higher WMH and lower Genu-FA represent poor brain health. HTN: Hypertension. Other potential variables were dropped out from the stepwise regression. 1564 participants are included in baseline analysis where 1396 are cognitively normal; 740 participants are included in the progression analysis, where 632 are cognitively normal.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Results from two regression (baseline) and two mixed models (progression) on WMH and WM health, Genu-FA.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Model #</th><th>Outcome</th><th>Predictors</th><th>Estimated effect size</th><th>SE</th><th><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11" altimg="si1.svg"><mml:mrow><mml:mi>P</mml:mi></mml:mrow></mml:math> value</th></tr></thead><tbody><tr><td># 1</td><td>Baseline WMH</td><td>Age</td><td align="char">0.053</td><td align="char">0.002</td><td align="char">&lt;0.001</td></tr><tr><td/><td/><td>Male</td><td align="char">−0.183</td><td align="char">0.033</td><td align="char">&lt;0.001</td></tr><tr><td/><td/><td>HTN</td><td align="char">0.172</td><td align="char">0.037</td><td align="char">&lt;0.001</td></tr><tr><td># 2</td><td>WMH progression</td><td>Age</td><td align="char">0.060</td><td align="char">0.003</td><td align="char">&lt;0.001</td></tr><tr><td/><td/><td>Male</td><td align="char">−0.207</td><td align="char">0.049</td><td align="char">&lt;0.001</td></tr><tr><td/><td/><td>HTN</td><td align="char">0.194</td><td align="char">0.053</td><td align="char">&lt;0.001</td></tr><tr><td># 3</td><td>Baseline Genu-FA</td><td>Age</td><td align="char">−0.002</td><td align="char">0.0001</td><td align="char">&lt;0.001</td></tr><tr><td/><td/><td>Male</td><td align="char">0.012</td><td align="char">0.0022</td><td align="char">&lt;0.001</td></tr><tr><td/><td/><td>HTN</td><td align="char">−0.010</td><td align="char">0.0024</td><td align="char">&lt;0.001</td></tr><tr><td># 4</td><td>Genu-FA progression</td><td>Age</td><td align="char">−0.002</td><td align="char">0.0002</td><td align="char">&lt;0.001</td></tr><tr><td/><td/><td>Male</td><td align="char">0.013</td><td align="char">0.0034</td><td align="char">0.001</td></tr><tr><td/><td/><td>HTN</td><td align="char">−0.011</td><td align="char">0.0036</td><td align="char">0.003</td></tr></tbody></table></div>WMH measurements are log-transformed. Higher WMH and lower Genu-FA represent poor brain health. HTN: Hypertension. Other potential variables were dropped out from the stepwise regression. 1564 participants are included in baseline analysis where 1396 are cognitively normal; 740 participants are included in the progression analysis, where 632 are cognitively normal.</transformed-table></extracted-table><extracted-table><table-id>t0015</table-id><table-label>Table 3</table-label><table-caption>Results from two standardized regression models on WMH with and without controlling for WM health, Genu-FA.</table-caption><table-wrap-foot>WMH measurements are log transformed before the standardized regression models.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="t0015" orientation="portrait"><label>Table 3</label><caption><p>Results from two standardized regression models on WMH with and without controlling for WM health, Genu-FA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Model #</th><th colspan="1" rowspan="1">Outcome</th><th colspan="1" rowspan="1">Predictors</th><th colspan="1" rowspan="1">Standardized effect size</th><th colspan="1" rowspan="1">SE</th><th colspan="1" rowspan="1"><inline-formula><mml:math id="M20" altimg="si1.svg"><mml:mrow><mml:mi>P</mml:mi></mml:mrow></mml:math></inline-formula> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"># 5</td><td colspan="1" rowspan="1">Baseline WMH</td><td colspan="1" rowspan="1">Genu-FA</td><td align="char" colspan="1" rowspan="1">−0.29</td><td align="char" colspan="1" rowspan="1">0.020</td><td align="char" colspan="1" rowspan="1">&lt;0.0001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Age</td><td align="char" colspan="1" rowspan="1">0.52</td><td align="char" colspan="1" rowspan="1">0.020</td><td align="char" colspan="1" rowspan="1">&lt;0.0001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Male</td><td align="char" colspan="1" rowspan="1">−0.06</td><td align="char" colspan="1" rowspan="1">0.017</td><td align="char" colspan="1" rowspan="1">0.0003</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">HTN</td><td align="char" colspan="1" rowspan="1">0.06</td><td align="char" colspan="1" rowspan="1">0.018</td><td align="char" colspan="1" rowspan="1">0.0004</td></tr><tr><td colspan="1" rowspan="1"># 6</td><td colspan="1" rowspan="1">Baseline WMH</td><td colspan="1" rowspan="1">Age</td><td align="char" colspan="1" rowspan="1">0.65</td><td align="char" colspan="1" rowspan="1">0.019</td><td align="char" colspan="1" rowspan="1">&lt;0.0001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Male</td><td align="char" colspan="1" rowspan="1">−0.10</td><td align="char" colspan="1" rowspan="1">0.018</td><td align="char" colspan="1" rowspan="1">&lt;0.0001</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">HTN</td><td align="char" colspan="1" rowspan="1">0.09</td><td align="char" colspan="1" rowspan="1">0.019</td><td align="char" colspan="1" rowspan="1">&lt;0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>WMH measurements are log transformed before the standardized regression models.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Results from two standardized regression models on WMH with and without controlling for WM health, Genu-FA.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Model #</th><th>Outcome</th><th>Predictors</th><th>Standardized effect size</th><th>SE</th><th><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M20" altimg="si1.svg"><mml:mrow><mml:mi>P</mml:mi></mml:mrow></mml:math> value</th></tr></thead><tbody><tr><td># 5</td><td>Baseline WMH</td><td>Genu-FA</td><td align="char">−0.29</td><td align="char">0.020</td><td align="char">&lt;0.0001</td></tr><tr><td/><td/><td>Age</td><td align="char">0.52</td><td align="char">0.020</td><td align="char">&lt;0.0001</td></tr><tr><td/><td/><td>Male</td><td align="char">−0.06</td><td align="char">0.017</td><td align="char">0.0003</td></tr><tr><td/><td/><td>HTN</td><td align="char">0.06</td><td align="char">0.018</td><td align="char">0.0004</td></tr><tr><td># 6</td><td>Baseline WMH</td><td>Age</td><td align="char">0.65</td><td align="char">0.019</td><td align="char">&lt;0.0001</td></tr><tr><td/><td/><td>Male</td><td align="char">−0.10</td><td align="char">0.018</td><td align="char">&lt;0.0001</td></tr><tr><td/><td/><td>HTN</td><td align="char">0.09</td><td align="char">0.019</td><td align="char">&lt;0.0001</td></tr></tbody></table></div>WMH measurements are log transformed before the standardized regression models.</transformed-table></extracted-table></extracted-tables-set>